MYX mayne pharma group limited

Mithra’s Donesta phase 3 trial results, page-3

  1. 14,890 Posts.
    lightbulb Created with Sketch. 1514
    The US menopause market is massive and if affected women can be given another option then that is great. Let's hope of continued success for Donesta and that Mithra and Mayne Pharma can do another deal and build on the significant marketing and distribution capability already established for Nextstellis.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.15
Change
-0.060(1.15%)
Mkt cap ! $411.9M
Open High Low Value Volume
$5.22 $5.25 $5.07 $448.3K 86.65K

Buyers (Bids)

No. Vol. Price($)
5 1146 $5.12
 

Sellers (Offers)

Price($) Vol. No.
$5.15 420 3
View Market Depth
Last trade - 12.23pm 23/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.